Your Source for Venture Capital and Private Equity Financings

Human API Announces $20M Series C Round

2020-11-03
SAN MATEO, CA, Human API announced today that it has raised over $20 million in Series C funding.
Human API, the company empowering consumers to connect and share electronic health data with companies they trust, announced today that it has raised over $20 million in Series C funding. The round includes participation from Samsung Ventures, CNO Financial Group, Allianz Life Ventures, and Moneta VC, as well as from existing investors BlueRun Ventures, SCOR Life and Health Ventures, and Guardian Life Insurance Company.

The capital will be used to scale new products and services that enable new product design, granular risk stratification, optimize clinical trial recruitment, support population health management, automate patient monitoring, and digitize chronic disease management. To drive forward this period of growth, Human API has brought on Richard Dufty as Chief Commercial Officer. Having spearheaded AppDirect's growth from early stage startup to Unicorn status in just 4 years, and having led Symantec's $1B US Consumer and Cloud business, Dufty brings extensive experience launching and growing software ecosystems.

Human API is on a mission to radically accelerate the pace of health innovation by giving consumers the easiest way to connect and share health data with companies they trust. The company has built a digital health data platform that connects, normalizes, and structures data from a rapidly-growing network of hospitals, pharmacies, labs, wearable devices and fitness apps, and EHR data partners. Human API empowers insurance, corporate wellness, health plans, digital therapeutics and clinical research organizations to build and deliver consumer-centric apps and services with electronic health records (EHR) and personal device data from everywhere. For more information, visit https://www.humanapi.co.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors